Inventor · disambiguated record
Ian Popoff
Also filed as: POPOFF IAN · POPOFF IAN J · POPOFF IAN JAMES
7 granted patents·7 pending applications·104 citations·filing 2000–2006
85Inventor score
Top patents by PatentIndex Score
14 records- 0190US6451602B1Antisense modulation of PARP expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Sep 17, 2002·35 cites·26 claims
- 0290US6379960B1Antisense modulation of damage-specific DNA binding protein 2, p48 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Apr 30, 2002·32 cites·26 claims
- 0383US6485974B1Antisense modulation of PTPN2 expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Nov 26, 2002·12 cites·26 claims
- 0483US6187587B1Antisense inhibition of e2f transcription factor 1 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Feb 13, 2001·19 cites·13 claims
- 0575US7981868B2Antisense modulation of p38 mitogen activated protein kinase expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Jul 19, 2011·3 cites·13 claims
- 0673US6165791AAntisense inhibition of E2F transcription factor 3 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Dec 26, 2000·3 cites·18 claims
- 0755US2007021367A1Modulation of SOCS-3 expressionPOPOFF IAN·Filed 2006·Application pending·0 cites
- 0854US2005186594A1Compositions and their uses directed to cell growth and maintenance proteinsFiled 2004·Application pending·0 cites
- 0951US2005197309A1Antisense modulation of dual specific phosphatase 5 expressionFiled 2005·Application pending·0 cites
- 1050US6855700B2Antisense modulation of damage-specific DNA binding protein 1, p127 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Feb 15, 2005·0 cites·19 claims
- 1143US2006160758A1Antisense modulation of CD40 ligand expressionBENNETT C F·Filed 2005·Application pending·0 cites
- 1242US2004048818A1Antisense modulation of e2f transcription factor 2 expressionFiled 2001·Application pending·0 cites
- 1340US2003006082A1Passenger safety handlebarFiled 2001·Application pending·0 cites
- 1440US2005191672A1Antisense oligonucleotides and RNA-interfering molecules targeting PAK4AGOURON PHARMA·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →